NYP/Columbia Univeresity Medical Center/Herbert Irving Comprehensive Cancer Center is a clinical research site located in New York, New York, United States 10032.
Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.
NYP/Columbia Univeresity Medical Center/Herbert Irving Comprehensive Cancer Center has participated in 1 clinical trials with 1 currently active.
Therapeutic areas: Triple Negative Breast Cancer, PD-L1 Positive.
Sponsors: Gilead Sciences.
Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
NYP/Columbia Univeresity Medical Center/Herbert Irving Comprehensive Cancer Center has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
NYP/Columbia Univeresity Medical Center/Herbert Irving Comprehensive Cancer Center has 1 clinical trials on record, with 1 currently active. Their work covers Triple Negative Breast Cancer, PD-L1 Positive.
NYP/Columbia Univeresity Medical Center/Herbert Irving Comprehensive Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.